Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Japan

Amgen Boosts Japan Sales Force, Eyeing New Products

June 2006 | Company Finance Alert

Leading US biotech Amgen is to strengthen its Japanese sales force, with the aim of assuming full control of marketing efforts for new cancer drugs. The company currently outsources all marketing activity to local firms, but aims to build a sales force of some 150 by 2010.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Novartis Plans OTC Market Assault

Companies / Japan Swiss drugmaker Novartis has launched its consumer healthcare division in Japan and it is planning to become a top 10 player within the next five years. Given the company's diversified portfolio of products...
January 2007
Eisai Opens New R&D Unit

Companies / Japan Japan's fourth-largest drugmaker, Eisai, has opened an R&D unit at the biotechnology research cluster in Kobe, Japan. The site will draw on the local research pool, specialising in developing new...
October 2006
Japan's Kyowa Hakko Invests In Antibodies

Companies / Japan Japanese pharmaceutical company Kyowa Hakko Kogyo is to invest some US$27mn on a new GMP-compliant animal cell culture unit. The expansion to the Fuji manufacturing facility is expected to begin in...
July 2006
Industry Slams Japan's Regulatory Reforms

Companies / Japan Stakeholders in Japan's drug industry have criticised the government's handling of its five-year industry plan. The strategy was first outlined in 2002, and a draft version of the new five-year plan...
June 2006
Takeda Boosts R&D Spend, Market Share

Companies / Japan Leading Japanese drugmaker Takeda is to invest US$1.8bn in research and development in fiscal year 2006/07, according to local reports. Other leading local firms are also expected to boost R&D budgets...
May 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS